An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent ...

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

Scientific breakthroughs take center stage at the International AIDS Society Conference as global HIV funding and political support erode.

With Black women and straight men increasingly at risk, Gilead’s Yeztugo may finally offer a discreet, stigma-free way to ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

This story first appeared in the UNAIDS Global AIDS Update 2025 report.

Healio received an APEX award for a 2024 report on the cloudy future of HIV vaccine research in the age of long-acting ...

I could only feel shocked at first, like the air was knocked out of my body. My first thought was: My life is over. This is ...

The Republican-led Senate rescued funding for PEPFAR in a package of spending cuts last month, but the HIV-prevention program ...

A new twice-yearly injection could be a new, more convenient tool for preventing HIV. Learn more about this new, preventative injection.

LONDON — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, ...